Research progress of stromal vascular fraction cells in the treatment of diabetic foot ulcer

doi:10.3877/cma.j.issn.1673-9450.2024.05.014

Abstract

Abstract:

Stromal vascular fraction cells are heterogeneous cells derived from adipose tissue that have the potential to proliferate, differentiate and paracrine, can promote angiogenesis at the transplantation site, and achieve revascularization and improved blood supply, promote the healing of diabetic foot ulcer. Therefore, stromal vascular fraction cells can be used in the treatment of diabetic foot ulcer, and have unique advantages and therapeutic value. This article reviews the mechanism of stromal vascular fraction cells in promoting the healing of diabetic foot ulcers, and hope for providing references for clinical research and treatment.

Key words: Diabetic foot, Ulcer, Neovascularization, physiologic, Stromal vascular fraction cell

Yao Bie, Zhibin Cao, Jing Xin, Jiannan Wang, Zongguang Hui. Research progress of stromal vascular fraction cells in the treatment of diabetic foot ulcer[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(05): 453-456.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2024.05.014

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2024/V19/I05/453

References 51

[1]	Carstens MH, Quintana FJ, Calderwood ST，et al.Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: safety and evidence of efficacy at 1 year[J].Stem Cells Transl Med，2021，10(8)：1138-1147.
[2]	万倩，周华，王脉桃．HIF-1α和SDF-1在糖尿病足大鼠创面中的表达及前列地尔的干预研究[J].遵义医科大学学报，2022，45(1)：46-51.
[3]	张皓琛，牛云飞．高压氧在糖尿病足溃疡治疗中的研究进展[J].中国糖尿病杂志，2023，31(8)：632-635.
[4]	Malekzadeh H，Tirmizi Z，Arellano JA，et al.Application of adipose-tissue derived products for burn wound healing[J]. Pharmaceuticals (Basel)，2023，16(9)：1302.
[5]	Bora P, Majumdar AS.Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation[J].Stem Cell Res Ther，2017，8(1)：145.
[6]	Goncharov EN，Koval OA，Igorevich EI，et al.Analyzing the clinical potential of stromal vascular fraction: a comprehensive literature review[J].Medicina (Kaunas)，2024，60(2)：221.
[7]	Zhang Y，Cai J，Zhou T，et al.Improved long-term volume retention of stromal vascular fraction gel grafting with enhanced angiogenesis and adipogenesis[J].Plast Reconstr Surg，2018，141(5)：676e-686e.
[8]	Zakhari JS，Zabonick J，Gettler B，et al.Vasculo-genic and angiogenic potential of adipose stromal vascular fraction cell populations in vitro[J].In Vitro Cell Dev Biol Anim，2018，54：32-40.
[9]	Jin E, Chae DS，Son M，et al.Angiogenic characteristics of human stromal vascular fraction in ischemic hindlimb[J].Int J Cardiol，2017，234：38-47.
[10]	Wang WZ.Microcirculatory response in vivo on local intraarterial infusion of autogenic adipose-derived stem cells or stromal vascular fraction[J].Plast Reconstr Surg Glob Open，2016，4(9)：e1067.
[11]	Zhang HM，Yang ML，Xi JZ，et al.Mesenchymal stem cells-based drug delivery systems for diabetic foot ulcer：a review[J]. World J Diabetes，2023，14(11)：1585-1602.
[12]	Azari Z，Nazarnezhad S，Webster TJ，et al.Stem cell-mediated angiogenesis in skin tissue engineering and wound healing[J].Wound Repair Regen，2022，30(4): 421-435.
[13]	Yu X，Liu P，Li Z，et al.Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds[J].Front Endocrinol (Lausanne)，2023，14：1099310.
[14]	Muinos-López E，Ripalda-Cemboráin P，López-Martínez T，et al.Hypoxia and reactive oxygen species homeostasis in mesenchymal progenitor cells define a molecular mechanism for fracture nonunion[J].Stem Cells，2016，34(9)：2342-2353.
[15]	Asadi R，Mostafavinia A，Amini A，et al.Acceleration of a delayed healing wound repair model in diabetic rats by additive impacts of photobiomodulation plus conditioned medium of adipose-derived stem cells[J].J Diabetes Metab Disord，2023，22(2)：1551-1560.
[16]	Trzyna A，Bana′s-Zabczyk A．Adipose-derived stem cells secretome and its potential application in "stem cell-free therapy" [J]. Biomolecules，2021，11(6)：878.
[17]	Ren G, Peng Q，Fink T，et al.Potency assays for human adipose-derived stem cells as a medicinal product toward wound healing[J].Stem Cell Res Ther，2022，13(1)：259.
[18]	Li Y, Zhi K，Han S，et al.TUG1 enhances high glucose-impaired endothelial progenitor cell function via miR-29c-3p/PDGF-BB/Wnt signaling[J].Stem Cell Res Ther，2020，15；11(1)：441.
[19]	Drela E, Stankowska K，Kulwas A，et al.Endothelial progenitor cells in diabetic foot syndrome[J].Adv Clin Exp Med，2012，21(2)：249-254.
[20]	Cao W, Cui J，Li S，et al.Crocetin restores diabetic endothelial progenitor cell dysfunction by enhancing NO bioavailability via regulation of PI3K/AKT-eNOS and ROS pathways[J].Life Sci，2017，181：9-16.
[21]	Tanaka R，Vaynrub M，Masuda H，et al.Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure[J].Diabetes，2013，62(9)：3207-3217.
[22]	Wang K，Dai X，He J，et al.Endothelial overexpression of metallothionein prevents diabetes-induced impairment in ischemia angiogenesis through preservation of HIF-1α/SDF-1/VEGF signaling in endothelial progenitor cells[J].Diabetes，2020，69(8)：1779-1792.
[23]	Kaushik K，Das A．Endothelial progenitor cell therapy for chronic wound tissue regeneration[J].Cytotherapy，2019，21(11)：1137-1150.
[24]	Sibal L，Aldibbiat A，Agarwal SC，et al.Circulating endothelial progenitor cells，endothelial function，carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria[J].Diabetologia，2009，52(8)：1464-1473.
[25]	Asai J，Takenaka H，Ii M，et al.Topical application of ex vivo expanded endothelial progenitor cells promotes vascularisation and wound healing in diabetic mice[J].Int Wound J，2013，10(5)：527-533.
[26]	Terriaca S, Fiorelli E，Scioli MG，et al.Endothelial progenitor cell-derived extracellular vesicles: potential therapeutic application in tissue repair and regen-eration[J].Int J Mol Sci，2021，22(12)：6375.
[27]	Han SK，Kim HR，Kim WK.The treatment of diabetic ulcers with unprocssed lipoaspirate cells：a pilot study[J].Wound Repair Regen，2010，18(4)：342-348.
[28]	Moon KC，Chung HY，Han SK，et al.Possibility of injecting adipose-derived stromal vascular fraction cells to accelerate microcirculation in ischemic diabetic feet: a pilot study[J].Int J Stem Cells，2019，12(1)：107-113.
[29]	Gentile P，Sterodimas A，Pizzicannella J，et al.Systematic review: allogenic use of stromal vascular fraction (SVF) and decellularized extracellular matrices (ECM) as advanced therapy medicinal products (ATMP) in tissue regeneration[J].Int J Mol Sci，2020，21(14)：4982.
[30]	Cai Y，Zhang F，Feng J，et al.Long-term follow-up and exploration of the mechanism of stromal vascular fraction gel in chronic wounds[J].Stem Cell Res Ther，2023，14(1)：163.
[31]	Tanios E，Ahmed TM，Shafik EA，et al.Efficacy of adipose-derived stromal vascular fraction cells in the management of chronic ulcers: a randomized clinical trial[J].Regen Med，2021，16(11)：975-988.
[32]	Tan S，Yeo X，Liang Z，et al.Stromal vascular fraction promotes fibroblast migration and cellular viability in a hyperglycemic microenvironment through up-regulation of wound healing cytokines[J].Exp Mol Pathol，2018，104(3)：250-255.
[33]	Chae DS，Han S，Son M，et al.Stromal vascular fraction shows robust wound healing through high chemotactic and epithelializa-tion property[J].Cytotherapy，2017，19(4)：543-554.
[34]	陈耀楠，王丹钰，袁倩，等．糖尿病足溃疡慢性伤口的形成机制及新型敷料的研究进展[J].中华糖尿病杂志，2023，15(2)：199-203.
[35]	Perez-Meza D，Ziering C，Sforza M，etal. Hair follicle growth by stromal vascular fraction-enhanced adipose transplantation in baldness[J].Stem Cells Cloning，2017，10：1-10.
[36]	Spiekman M, Van Dongen JA，Willemsen JC，et al，The power of fat and its adipose-derived stromal cells: emerging concepts for fibrotic scar treatment[J].Tissue Eng Regenerat Med，2017，11(11)：3220-3235.
[37]	Tan SS, Yeo XY，Liang ZC，et al.Stromal vascular fraction promotes fibroblast migration and cellular viability in a hyperglycemic microenvironment through up-regulation of wound healing cytokines[J] Exp Mol.Pathol，2018，104(3)：250-255.
[38]	Rodriguez-Merchan EC.Autologous and allogenic utilization of stromal vascular fraction and decellularized extracellular matrices in orthopedic surgery: a scoping review[J].Arch Bone Jt Surg，2022，10(10)：827-832.
[39]	Didangelos T, Koliakos G，Kouzi K，et al.Accelerated healing of a diabetic foot ulcer using autologous stromal vascular fraction suspended in platelet-rich plasma[J].Regen Med，2018，13(3)：277-281.
[40]	高长春，张雪松，崔磊，等．脂肪干细胞对于同种异体脂肪移植免疫排斥反应的抑制作用[J].黑龙江医学，2020，44(6)：740-743.
[41]	Pyšná A，Bém R, Němcová A，et al.Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential[J].Stem Cell Rev Rep，2019，15(2)：157-165.
[42]	Trivisonno A, Alexander RW，Baldari S，et al.Intraoperative strategies for minimal manipulation of autologous adipose tissue for cell- and tissue-based therapies：concise review[J].Stem Cells Transl Med，2019，8(12)：1265-1271.
[43]	Moon KC, Chung HY，Han SK，et al.Possibility of injecting adipose-derived stromal vascular fraction cells to accelerate microcirculation in ischemic diabetic feet: a pilot study[J].Int J Stem Cells，2019，12(1)：107-113.
[44]	Cheng C，Sheng L，Li H，et al.Cell-assisted skin grafting: improving texture and elasticity of skin grafts through autologous cell transplantation[J].Plast Reconstr Surg，2016，137(1)：58e-66e.
[45]	Giudice G，Filoni A，Maggio G，et al.Use of the stromal vascular fraction in intermediate-deep acute burns: a case with its own control[J].J Burn Care Res，2018，39(5)：846-849.
[46]	Stachura A，Paskal W，Pawlik W，et al.The use of adipose-derived stem cells (ADSCs) and stromal vascular fraction (SVF) in skin scar treatment-a systematic review of clinical studies[J].J Clin Med，2021，10(16)：3637.
[47]	Zahorec P，Sarkozyova N，et al.Autologous mesenchymal stem cells application in post-burn scars treatment: a preliminary study[J].Cell Tissue Bank，2021，22(1)：39-46.
[48]	Uhl JF，Sufianov A，Ruiz C，et al.The use of 3D printed models for surgical simulation of cranioplasty in craniosynostosis as training and education[J].Brain Sci，2023，13(6)：894.
[49]	Montemurro N，Condino S，Carbone M，et al.Brain tumor and augmented reality：new technologies for the future[J].Int J Environ Res Public Health，2022，19(10)：6347.
[50]	Fortunato GM，Sigismondi S，Nicoletta M，et al.Analysis of the robotic-based in situ bioprinting workflow for the regeneration of damaged tissues through a case study[J].Bioengineering(BASEL)，2023，10(5): 560.
[51]	Encarnacion Ramirez M，Ramirez Pena I，Barrientos Castillo Re，et al.Development of a 3d printed brain model with vasculature for neurosurgical procedure visualisation and training[J]. Biomedicines，2023，11(2)：330.

Please choose a citation manager

Content to export